Spinal Modulation Completes $27.4M Series C Financing

Spinal Modulation, Inc., a Menlo Park, CA-based medical device company, completed its $27.4m Series C financing.

Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates, in this round of financing.
DFJ/InCube Ventures and Raffles Venture Partners are additional new investors.
The funds will be used to support further development of the company’s next generation spinal cord stimulator system to treat patients suffering from chronic intractable pain.

Join the discussion